期刊文献+

前列地尔对不稳定型心绞痛患者应用造影剂后肾血流动力学的影响 被引量:8

Effects of alprostadil on renal hemodynamics in patients with unstable angina after using contrast media
下载PDF
导出
摘要 目的探讨前列地尔对不稳定型心绞痛患者应用造影剂后肾血流动力学的影响。方法56例不稳定型心绞痛患者分为两组,行冠状动脉造影术(必要时行冠状动脉介入治疗),对照组(n=28)给予常规治疗,实验组(n=28)在常规治疗的基础上术前30 min加用前列地尔注射液10μg静脉注射,术后连续静脉注射3 d。观察(1)两组患者治疗后的肾动脉血流动力学的变化;(2)两组患者治疗后血清肌酐浓度变化。结果(1)实验组的肾血流动力学指标如收缩期最大血流速度[(82.72±4.02)cm/s vs.(74.52±3.75)cm/s,P<0.05]、舒张末期最低血流速度[(33.65±3.18)cm/s vs.(28.03±2.23)cm/s,P<0.05]、肾血流量[(588±112)mL/min vs.(521±105)mL/min,P<0.05]均较对照组显著增加,阻力指数明显降低(0.60±0.05 vs.0.68±0.07,P<0.05),差异均有统计学意义;(2)实验组术后48 h起血清肌酐浓度明显低于对照组,差异有统计学意义(P<0.05)。结论前列地尔可增加不稳定型心绞痛患者应用造影剂后肾动脉的灌注,改善肾脏的缺血状态,有益于保护肾功能。 Objectives To explore the effects of alprostadil on renal hemodynamics after the application of contrast media in patients with unstable angina. Methods Fifty six patients with unstable angina underwent coronary angiography (if necessary, coronary intervention therapy) were randomly divided into two groups. Control group (n =28) received conventional therapy, while experimental group (n=28) received 10 μg alprostadil intravenously 30 minutes before the routine treatment and lasted for 3 days after treatment. Both group were continuously observed for three days after the treatment. (1) Changes of the post-treatment renal hemodynamics and (2) serum concentrations of creatinine (SCr) in both group were carefully observed. Results ( l ) Indicators of renal hemodynamics such as systolic blood flow velocity [(82.72 ± 4.02) cm/s vs. (74.52 ± 3.75) cm/s, P〈0.05], minimum diastdic flow velocity [(33.65 ± 3.18) cm/s vs. (28.03 ± 2.23) era/s, P〈0.05], renal blood flow[(588±112) mL/min vs. (521 ± 105) mL/min, P〈0.05] in experimental group were significantly higher than those in control group, while vascular resistance index (0.60 ± 0.05 vs. 0.68 ± 0.07, P〈0.05) in experimental group was significantly lower than that in control group. (2)Serum concentrations of SCr 48 hours after the starting of the procedure in experimental group were significantly lower than those in control group(P〈0.05 ). Conclusions Alprostadil may protects renal function in patients with unstable angina after using contrast media by increasing renal artery perfusion, and therefore improve renal ischemia.
出处 《岭南心血管病杂志》 2012年第1期30-32,共3页 South China Journal of Cardiovascular Diseases
基金 广东省医学科研基金(项目编号:A2011481) 广州市医药卫生科技项目(项目编号:201102A213206)
关键词 心绞痛 冠状动脉造影术 前列地尔 造影剂 肾血流 angina coronary angiography alprostadil contrast media renal blood flow
  • 相关文献

参考文献8

  • 1JENNIFER V. Prevention of rad~ocontrast induced nephr- opathy[J]. Drug Ther Top, 2004, 33(3) : 15.
  • 2柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2108
  • 3THOMSEN H S. Guidelines for contrast media from the european society of urogenital radiology[J]. AJR Am J Roentgenol, 2003, 181 (6) : 1463-1471.
  • 4LIISTRO F, FALSINI G, BOLOGNESE L. The clinical burden of contrast media-induced nephropathy[ J ]. Ital Heart J, 2003, 4(10): 668.
  • 5JENNIFER V.Prevention of radiocontrast induced nephr-opathy [J]. Drug Ther Top, 2004, 33(3): 15-20.
  • 6孙脊峰,赵柏山,焦凯,杨洁,李占亭,杜德伟,段云友.前列腺素E_1对糖尿病肾病患者肾动脉血流动力学的影响[J].第四军医大学学报,2006,27(7):642-644. 被引量:20
  • 7MAHMOUD I M, HUSSEIN AEL A, SARHAN M E, et al. Role of combined L-arginine and prostaglandin E1 in renal ischemia-reperfusion injury [J]. Nephron Physiol, 2007, 105 (4) : 57-65.
  • 8OKADA S, ICI-IIKI K, TANOKUCHI S, et al. Effect of prostaglandin E1 on the renin- aldosterone system in patients with diabetic nephropathy[J]. J Int Med Res, 1993, 21 (3): 126-132.

二级参考文献31

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:193
  • 2Lansang MC,Hollenberg NK.Renal perfusion and the renal hemodynamic response to blocking the renin system in diabetes:Are the forces leading to vasodilation and vasoconstriction linked[J]? Diabetes,2002,51:2025-2028.
  • 3Haneda M,Koya D,Isono M,et al.Overview of glucose signaling in mesangial cells in diabetic nephropathy[J].J Am Soc Nephrol,2003,14:1374-1382.
  • 4Evans JL,Goldfine ID,Maddux BA,et al.Oxidative stress and stress-activated signaling pathways:A unifying hypothesis of type 2 diabetes[J].Endocr Rev,2002,23:599-622.
  • 5Vinik AI,Vinik E.Prevention of the complications of diabetes[J].Am J Manag Care,2003,9:S63-S80.
  • 6Nicholls K.Diabetic nephropathyhow might we prevent,retard,or cope with it[J]? Aust Fam Physician,2005,34:933-936.
  • 7Shlipak M.Diabetic nephropathy[J].Clin Evid,2004,12:814-833.
  • 8Wolf G,Chen S,Ziyadeh FN.From the periphery of the glomerular capillary wall toward the center of disease:Podocyte injury comes of age in diabetic nephropathy[J].Diabetes,2005,54:1626-1634.
  • 9Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.
  • 10Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840.

共引文献2126

同被引文献73

引证文献8

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部